J. Zou

6.1k total citations
7 papers, 243 citations indexed

About

J. Zou is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Zou has authored 7 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Zou's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). J. Zou is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). J. Zou collaborates with scholars based in United States, Taiwan and South Korea. J. Zou's co-authors include Giuseppe Lentini, Ann‐Lii Cheng, Yoon‐Koo Kang, D. Voliotis, Zhongzhen Guan, Fang Fang, Shiying Yu, Won Young Tak, Hongming Pan and Shukui Qin and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

J. Zou

7 papers receiving 237 citations

Peers

J. Zou

HEPAT

PFM

EPIDE

SURGE

CR

Guohong Han China

Le-Qun Li China

Songqiang Zhou China

Xuqi Sun China

Fei Cao China

Yu-Jie Xu China

Kenichiro Kodama Japan

Naoki Kamachi Japan

Cheng‐Qian Zhong China

Annette Baumhauer Spain

Guohong Han China

J. Zou

218 ×1.1

HEPAT

74 ×1.0

PFM

81 ×1.2

EPIDE

49 ×0.9

SURGE

51 ×1.1

CR

Citations per year, relative to J. Zou J. Zou (= 1×) peers Guohong Han

Countries citing papers authored by J. Zou

Since Specialization

Citations

This map shows the geographic impact of J. Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Zou more than expected).

Fields of papers citing papers by J. Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Zou. The network helps show where J. Zou may publish in the future.

Co-authorship network of co-authors of J. Zou

This figure shows the co-authorship network connecting the top 25 collaborators of J. Zou. A scholar is included among the top collaborators of J. Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Zou. J. Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Al‐Noori, Salwa, et al.. (2016). Brown adipose tissue thermogenesis does not explain the intra-administration hyperthermic sign-reversal induced by serial administrations of 60% nitrous oxide to rats. Journal of Thermal Biology. 60. 195–203. 4 indexed citations

2.

Cheng, Ann‐Lii, Zhongzhen Guan, Zhendong Chen, et al.. (2012). Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial. European Journal of Cancer. 48(10). 1452–1465. 222 indexed citations

3.

Sartor, Oliver, Robert E. Coleman, Sten Nilsson, et al.. (2012). Safety of Cytotoxic Chemotherapy Following Radium-223 Chloride (RA-223) Therapy in the Phase 3 Alsympca Study in Patients with Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. Annals of Oncology. 23. ix308–ix309. 6 indexed citations

4.

Yang, T.-S., Shenghui Qin, Won Young Tak, et al.. (2009). Impact of prior surgical resection with curative intent on the efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma (HCC): Subset analysis of the Asia-Pacific (AP) study. Journal of Clinical Oncology. 27(15_suppl). e15518–e15518. 1 indexed citations

5.

Raoul, Jean‐Luc, Ann‐Lii Cheng, Yubin Kang, et al.. (2009). 6621 Effect of macroscopic vascular invasion (MVI), extrahepatic spread (EHS), and ECOG performance status (ECOG PS) on outcome in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib: analysis of two phase III, randomized, double-blind trials. European Journal of Cancer Supplements. 7(2). 396–396. 1 indexed citations

6.

Qin, Shenghui, Won Young Tak, Shaoqing Yu, et al.. (2009). Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma (HCC): Asia-Pacific (AP) trial subgroup analyses by baseline transaminase (ALT/AST)/α-fetoprotein (AFP) levels. Journal of Clinical Oncology. 27(15_suppl). 4590–4590. 1 indexed citations

7.

Bruix, Jordi, Ann‐Lii Cheng, Yoon‐Koo Kang, et al.. (2009). Effect of macroscopic vascular invasion (MVI), extrahepatic spread (EHS), and ECOG performance status (ECOG PS) on outcome in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib: Analysis of two phase III, randomized, double-blind trials. Journal of Clinical Oncology. 27(15_suppl). 4580–4580. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact